Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MDA-MB-231 | Erlotinib | 0.1 | uM | 10 | 156.25 | 67.09 | 175.00 | 198.00 | 0.8838 | 0.8479 |
| MDA-MB-231 | 0 | uM | 10 | 156.25 | 67.09 | 331.00 | 198.00 | 1.6717 | 1.7795 | |
| MDA-MB-231 | Linsitinib | 0.1 | uM | 10 | 156.25 | 67.09 | 303.00 | 198.00 | 1.5303 | 1.6265 |
| MDA-MB-231 | Lapatinib | 0.0016596 | uM | 10 | 156.25 | 67.09 | 204.00 | 198.00 | 1.0303 | 1.0386 |
| MDA-MB-231 | Lapatinib | 0.0033113 | uM | 10 | 156.25 | 67.09 | 192.00 | 198.00 | 0.9697 | 0.9610 |
| MDA-MB-231 | Linsitinib | 1 | uM | 10 | 156.25 | 67.09 | 198.00 | 198.00 | 1.0000 | 1.0000 |
| MDA-MB-231 | Lapatinib | 0.01 | uM | 10 | 156.25 | 67.09 | 218.00 | 198.00 | 1.1010 | 1.1271 |
| MDA-MB-231 | Linsitinib | 0.031623 | uM | 10 | 156.25 | 67.09 | 140.00 | 198.00 | 0.7071 | 0.6018 |
| MDA-MB-231 | 17-AAG | 1 | uM | 10 | 156.25 | 67.09 | 110.00 | 198.00 | 0.5556 | 0.3726 |
| MDA-MB-231 | 0 | uM | 10 | 156.25 | 67.09 | 211.00 | 198.00 | 1.0657 | 1.0831 | |
| MDA-MB-231 | Lapatinib | 0.1 | uM | 10 | 156.25 | 67.09 | 189.00 | 198.00 | 0.9546 | 0.9413 |
| MDA-MB-231 | Lapatinib | 0.031623 | uM | 10 | 156.25 | 67.09 | 254.00 | 198.00 | 1.2828 | 1.3459 |
| MDA-MB-231 | 0 | uM | 10 | 156.25 | 67.09 | 96.00 | 198.00 | 0.4849 | 0.2580 | |
| MDA-MB-231 | 0 | uM | 10 | 312.50 | 120.45 | 454.00 | 495.75 | 0.9158 | 0.9156 | |
| MDA-MB-231 | 17-AAG | 3.1623 | uM | 10 | 312.50 | 120.45 | 136.00 | 495.75 | 0.2743 | 0.0613 |
| MDA-MB-231 | Erlotinib | 0.01 | uM | 10 | 312.50 | 120.45 | 725.00 | 495.75 | 1.4624 | 1.4094 |
| MDA-MB-231 | Linsitinib | 3.1623 | uM | 10 | 312.50 | 120.45 | 473.00 | 495.75 | 0.9541 | 0.9545 |
| MDA-MB-231 | Erlotinib | 0.0033113 | uM | 10 | 312.50 | 120.45 | 551.00 | 495.75 | 1.1114 | 1.1063 |
| MDA-MB-231 | Lapatinib | 10 | uM | 10 | 312.50 | 120.45 | 291.00 | 495.75 | 0.5870 | 0.5406 |
| MDA-MB-231 | Linsitinib | 0.0033113 | uM | 10 | 312.50 | 120.45 | 642.00 | 495.75 | 1.2950 | 1.2700 |
| MDA-MB-231 | Erlotinib | 3.1623 | uM | 10 | 312.50 | 120.45 | 654.00 | 495.75 | 1.3192 | 1.2907 |
| MDA-MB-231 | Lapatinib | 1 | uM | 10 | 312.50 | 120.45 | 692.00 | 495.75 | 1.3959 | 1.3550 |
| MDA-MB-231 | Lapatinib | 0.31623 | uM | 10 | 312.50 | 120.45 | 851.00 | 495.75 | 1.7166 | 1.6062 |
| MDA-MB-231 | Erlotinib | 10 | uM | 10 | 312.50 | 120.45 | 569.00 | 495.75 | 1.1478 | 1.1397 |
| MDA-MB-231 | Erlotinib | 19.9526 | uM | 10 | 312.50 | 120.45 | 538.00 | 495.75 | 1.0852 | 1.0818 |